Regn investor alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of regeneron pharmaceuticals, inc.

New york , july 13, 2023 /prnewswire/ -- levi & korsinsky notifies investors that it has commenced an investigation of regeneron pharmaceuticals, inc. ("regeneron") (nasdaq: regn) concerning possible violations of federal securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
REGN Ratings Summary
REGN Quant Ranking